SA329 & 140/4 (47 ov)
AUS429
BAN272
WI134/4 (48 ov)
NZ
IND
NAM
IRE
Abha
Al Ittihad
NorthEast
Bengaluru
Al Diriyah
Neom SC
Le Havre AC
PSG
Nice
Rennes
Al Shabab
Al Ahli
FIO2
ATA2
NSR5
KHO3
RIY0
QAD6
FRO5
LEC1
SBP172 & 165/7 (59.4 ov, target 237)
MITS112 & 296
SOA154
WA406/5d & 79/6 (29 ov)
UAE
NED
PAK
SL
BH-W
SS-W
AS-W
MS-W
PS-W
MR-W
MIS
TOK
AFG221/7
ZIM202/5 (20 ov, target 222)
ENG386/5
OMA196
HH-W174/8 (20 ov, target 193)
ST-W140/4 (17/20 ov, target 139)
MOW185/3
VAG90/9 (20 ov, target 186)
SCR2
ALM2
FDU0
CCSU0
Elversberg
Mainz
Villarreal
Espanyol
KHA4
HAZ2
Genoa2
Juventus0
Mankind Pharma, India’s fourth largest pharmaceutical company, has announced a groundbreaking collaboration with OpenAI to become one of the first Indian pharma companies fully integrating advanced AI across its entire value chain.
Table of Contents
Mankind Pharma’s AI-First Transformation
This partnership represents a pivotal shift in Indian healthcare, with Mankind integrating ChatGPT Enterprise and GPT-5 across multiple critical functions to accelerate innovation and improve operational efficiency.
| Function | AI Application | Impact |
|---|---|---|
| Field Force | Real-time performance tracking | Measurable effectiveness improvements |
| R&D | Clinical intelligence & literature reviews | Accelerated scientific discovery |
| Manufacturing | Batch record analysis & anomaly detection | Proactive quality control |
| Medical Affairs | Compliant multilingual communication | Faster, accurate regulatory compliance |
Leadership Vision for Healthcare Future
Arjun Juneja, COO of Mankind Pharma, emphasizes the strategic importance: “This is not just about automation; it’s about creating a more responsive, intelligent, and future-ready enterprise. We’re excited to lead this shift in Indian pharma and set new benchmarks for how technology can drive both operational excellence and long-term value creation.”
Revolutionary AI Capabilities
Since July 2025, Mankind has deployed customized GPTs across its workforce, transforming operations through:
- Smart Decision-Making: GPT-powered dashboards providing real-time insights across R&D, supply chain, and commercial operations
- Regulatory Compliance: Automated, multilingual content for healthcare professionals ensuring speed and accuracy
- Function-Specific Agents: Dedicated AI assistants for Sales, Marketing, R&D, and HR teams
- Manufacturing Excellence: AI analyzing sensor data to detect anomalies early with unmatched accuracy
Industry Recognition
Oliver Jay, Managing Director International at OpenAI, highlights the collaboration’s significance: “Mankind Pharma’s company-wide adoption of ChatGPT Enterprise shows the practical role AI can play in regulated industries such as pharmaceuticals.”
Mankind’s Market Leadership
With impressive credentials including:
- 17,700+ field force professionals
- 30 manufacturing facilities across India
- 6 dedicated R&D centers with 730+ scientists
- Pan-India presence reaching 500,000+ doctors
This AI integration positions Mankind at the forefront of pharmaceutical innovation, setting new industry standards for technology-driven healthcare delivery and operational excellence in the rapidly evolving Indian pharmaceutical landscape.
